Highlights from this issue
Thorax
Tiotropium Respimat increases the risk of mortality
Omalizumab
The activin A antagonist follistatin inhibits asthmatic airway remodelling
Clinical control of asthma associates with measures of airway inflammation
Cod liver oil intake and incidence of asthma in Norwegian adults—the HUNT study
Correction
Proteolytic activity in cowshed dust extracts induces C5a release in murine bronchoalveolar lavage fluids which may account for its protective properties in allergic airway inflammation
Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis
A molecular assay to predict survival in resected non-squamous non-small-cell lung cancer
Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease
The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status
Human respiratory syncytial virus viroporin SH
Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF
IL-25 drives remodelling in allergic airways disease induced by house dust mite
Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing
Correction
Wake-up stroke and TIA due to paradoxical embolism during long obstructive sleep apnoeas
Chest MRI in patients with cystic fibrosis
Authors' response
Authors’ response
Is Cheyne-Stokes respiration friend or foe of heart failure?
Novel insights into immune and inflammatory responses to respiratory viruses
Nicotine replacement therapy in pregnancy
Extrapulmonary lymphangioleiomyomatosis
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications
Aggravating cough in a patient with suspected sarcoidosis